Thursday, April 16, 2020 10:50:35 PM
Here’s a thought experiment
If Pure CBD (CBD Isolate) in Foods, Beverages and Dietary Supplements were legalized tomorrow (that’s what HR 5587 would legalize), and investors on the sidelines start compiling a list of stocks in the sector they are interested in buying, VATE has a high probability of being on the most lists and becoming the most popular choice of investors in the newly legal Pure CBD Sector (not Full Spectrum CBD , not Broad Spectrum CBD, just CBD)
And here’s why
The opportunity to get in on the ground floor of a CBD Beverage stock selling the most popular beverages in America — Coffee and Tea — will be a large magnet for investment
When there is only 1 publicly traded company in America doing so — that will make VATE irresistible to many investors
Water is a very popular beverage, too, and CBD-infused water has been the choice of beverage for nearly all CBD Beverage stocks — so there are at least 6 different CBD Water stocks but only 1 CBD Coffee and Tea stock — that categorical difference alone will make VATE a more popular choice of investors than any single CBD Water stock
Now let’s exit this thought experiment and get back to reality
CBD Legalization is not happening tomorrow
But it could very well happen in May
That is when the Phase Four Covid-19 Stimulus Bill is projected to pass
Nancy Pelosi has recently stated she wants Cannabis Banking (MJ and Hemp) to be included in this economic recovery bill:
https://www.marijuanamoment.net/pelosi-wants-marijuana-businesses-included-in-next-coronavirus-relief-bill-congressman-says/
Will the Senate approve MJ Banking?
I don’t know, there’s still a great deal of opposition to this amongst Republican Party leadership, so it’s tough to say
Will the Senate approve Hemp Banking?
Absolutely, there is tremendous support for it and zero opposition
Hemp has been federally legalized and completely descheduled — MJ is federally illegal and a Schedule 1 Substance — so there’s an enormous difference there
Jonathan Miller predicted that legislation for CBD Legalization in Foods, Beverages and Dietary Supplements would be filed in November 2019
In January 2020, HR 5587 was filed — Miller nailed it
Jonathan Miller is more connected than anybody — he is basically Mitch’s personal lobbyist for Hemp
Last week, Miller stated that the Phase Four Covid-19 Stimulus Bill is the right legislative vehicle for CBD Legalization in Foods, Beverages and Supplements
Watch him provide details in this video starting at 12:30
https://m.facebook.com/story.php?story_fbid=517338882233397&id=2043552242529673&_rdr
So Hemp Banking and CBD Legalization passing inside of the Phase Four Covid-19 Stimulus Bill in May is a very plausible outcome
Last time I checked it was already mid-April
VATE is a no-brainer at these prices given the legislative possibilities this Spring
Sleek
If Pure CBD (CBD Isolate) in Foods, Beverages and Dietary Supplements were legalized tomorrow (that’s what HR 5587 would legalize), and investors on the sidelines start compiling a list of stocks in the sector they are interested in buying, VATE has a high probability of being on the most lists and becoming the most popular choice of investors in the newly legal Pure CBD Sector (not Full Spectrum CBD , not Broad Spectrum CBD, just CBD)
And here’s why
The opportunity to get in on the ground floor of a CBD Beverage stock selling the most popular beverages in America — Coffee and Tea — will be a large magnet for investment
When there is only 1 publicly traded company in America doing so — that will make VATE irresistible to many investors
Water is a very popular beverage, too, and CBD-infused water has been the choice of beverage for nearly all CBD Beverage stocks — so there are at least 6 different CBD Water stocks but only 1 CBD Coffee and Tea stock — that categorical difference alone will make VATE a more popular choice of investors than any single CBD Water stock
Now let’s exit this thought experiment and get back to reality
CBD Legalization is not happening tomorrow
But it could very well happen in May
That is when the Phase Four Covid-19 Stimulus Bill is projected to pass
Nancy Pelosi has recently stated she wants Cannabis Banking (MJ and Hemp) to be included in this economic recovery bill:
https://www.marijuanamoment.net/pelosi-wants-marijuana-businesses-included-in-next-coronavirus-relief-bill-congressman-says/
Will the Senate approve MJ Banking?
I don’t know, there’s still a great deal of opposition to this amongst Republican Party leadership, so it’s tough to say
Will the Senate approve Hemp Banking?
Absolutely, there is tremendous support for it and zero opposition
Hemp has been federally legalized and completely descheduled — MJ is federally illegal and a Schedule 1 Substance — so there’s an enormous difference there
Jonathan Miller predicted that legislation for CBD Legalization in Foods, Beverages and Dietary Supplements would be filed in November 2019
In January 2020, HR 5587 was filed — Miller nailed it
Jonathan Miller is more connected than anybody — he is basically Mitch’s personal lobbyist for Hemp
Last week, Miller stated that the Phase Four Covid-19 Stimulus Bill is the right legislative vehicle for CBD Legalization in Foods, Beverages and Supplements
Watch him provide details in this video starting at 12:30
https://m.facebook.com/story.php?story_fbid=517338882233397&id=2043552242529673&_rdr
So Hemp Banking and CBD Legalization passing inside of the Phase Four Covid-19 Stimulus Bill in May is a very plausible outcome
Last time I checked it was already mid-April
VATE is a no-brainer at these prices given the legislative possibilities this Spring
Sleek
SLEEKSCAPE’S GRAND SALAMI FOR 2020 HEMP & CBD MANIA -- PART II
https://investorshub.advfn.com/$LEEK$CAPE’S-2020-HEMP-CBD-&-MARIJUANA-MANIA-GRAND-SALAMI-PART-II-31243/
Recent BLEG News
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • InvestorsHub NewsWire • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • GlobeNewswire Inc. • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • InvestorsHub NewsWire • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • GlobeNewswire Inc. • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • GlobeNewswire Inc. • 12/10/2025 02:17:29 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • InvestorsHub NewsWire • 12/10/2025 02:00:00 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • GlobeNewswire Inc. • 11/25/2025 03:38:40 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • InvestorsHub NewsWire • 11/25/2025 03:11:49 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • InvestorsHub NewsWire • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • GlobeNewswire Inc. • 10/22/2025 03:17:40 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • InvestorsHub NewsWire • 10/22/2025 02:56:16 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • InvestorsHub NewsWire • 09/30/2025 12:30:00 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • GlobeNewswire Inc. • 09/30/2025 12:30:00 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • GlobeNewswire Inc. • 09/23/2025 02:44:55 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • InvestorsHub NewsWire • 09/23/2025 01:40:59 PM
- Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver • InvestorsHub NewsWire • 09/04/2025 12:30:00 PM
- Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions • InvestorsHub NewsWire • 08/22/2025 05:39:40 PM
- Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways • InvestorsHub NewsWire • 08/19/2025 12:39:04 PM
- Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery • InvestorsHub NewsWire • 08/12/2025 12:30:00 PM
- Branded Legacy, Inc. Signs Letter of Intent to Acquire Bio-Legacy Evaluative Group, Advancing Innovations in Intranasal Drug Delivery • InvestorsHub NewsWire • 07/29/2025 12:30:00 PM
- Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • InvestorsHub NewsWire • 07/14/2025 05:23:12 PM
